Eurofins Scientific SE Stock
Stocks
ERF
FR0014000MR3
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.28 EUR | +1.12% |
|
+1.91% | +12.63% |
| 06-30 | NFL Biosciences validates industrial-scale production of NFL-102 for smoking cessation |  |
| 06-24 | Eurofins Scientific SE acquired Weatherbys Scientific. | CI |
| Market Cap | 12.28B 14.03B 11.35B 10.44B 19.67B 1,352B 20.12B 136B 53.29B 662B 52.69B 51.53B 2,281B | P/E 2026 * |
24.4x | P/E 2027 * | 18.7x |
|---|---|---|---|---|---|
| Enterprise Value | 15.72B 17.96B 14.53B 13.36B 25.19B 1,731B 25.76B 174B 68.23B 847B 67.46B 65.97B 2,920B | EV / Sales 2026 * |
2.07x | EV / Sales 2027 * | 1.9x |
| Free-Float |
58.35% | Yield 2026 * |
1.1% | Yield 2027 * | 1.28% |
Last Transcript: Eurofins Scientific SE
| 1 day | +1.12% | ||
| 1 week | +1.91% | ||
| Current month | +2.51% | ||
| 1 month | +12.41% | ||
| 3 months | +0.63% | ||
| 6 months | -2.28% | ||
| Current year | +12.63% |
| 1 week | 68.12 |  | 70.84 |
| 1 month | 62.16 | | 70.84 |
| Current year | 56.84 | | 74.32 |
| 1 year | 54.86 | | 74.32 |
| 3 years | 39.47 | | 74.32 |
| 5 years | 39.47 | | 127.68 |
| 10 years | 29.82 | | 127.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 63 | 01/01/1987 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 01/01/2015 |
Christian Wurst
PRN | Corporate Officer/Principal | 53 | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 63 | 01/01/1987 |
Yves-Loïc Martin
BRD | Director/Board Member | 60 | 01/01/2015 |
Valérie Hanote
BRD | Director/Board Member | 60 | 01/01/1990 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 27/4/26 | Buy | 700 | 0.0004% | |||
| 19/4/26 | Fiscal year | Executive/Senior Manager | 700 | 0.0004% | ||
| 19/4/26 | Sell | Executive/Senior Manager | 500 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.12% | +1.91% | +14.54% | +15.44% | 14.05B | |
| -1.29% | -3.11% | -0.35% | +2.64% | 49.18B | |
| +3.90% | -0.39% | +386.06% | +588.97% | 39.58B | |
| -1.70% | +4.46% | +5.93% | +61.54% | 34.69B | |
| -2.01% | -0.76% | +28.41% | -8.52% | 34.42B | |
| +0.06% | +0.34% | +2.38% | +34.38% | 27.11B | |
| +0.46% | -3.49% | - | - | 16.21B | |
| -0.04% | -0.09% | +72.42% | +116.45% | 15.36B | |
| 0.00% | +1.36% | +18.43% | -31.23% | 13.02B | |
| -0.08% | -3.01% | +1,282.83% | +619.81% | 11.76B | |
| Average | +0.04% | -0.28% | +201.18% | +155.50% | 25.54B | |
| Weighted average by Cap. | -0.05% | -0.31% | +138.60% | +146.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.6B 8.68B 7.02B 6.46B 12.17B 837B 12.45B 83.98B 32.98B 409B 32.61B 31.89B 1,411B | 8.07B 9.22B 7.46B 6.86B 12.93B 889B 13.23B 89.22B 35.04B 435B 34.64B 33.88B 1,499B |
| Net income | 517M 590M 477M 439M 828M 56.89B 846M 5.71B 2.24B 27.83B 2.22B 2.17B 95.94B | 676M 773M 625M 575M 1.08B 74.46B 1.11B 7.47B 2.93B 36.42B 2.9B 2.84B 126B |
| Net Debt | 3.44B 3.93B 3.18B 2.93B 5.51B 379B 5.64B 38.03B 14.94B 185B 14.77B 14.44B 639B | 3.08B 3.52B 2.85B 2.62B 4.94B 340B 5.05B 34.09B 13.38B 166B 13.23B 12.94B 573B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | €70.28 | +1.12% | 272,834 |
| 16/07/26 | €69.50 | +0.29% | 169,938 |
| 15/07/26 | €69.30 | +0.43% | 273,072 |
| 14/07/26 | €69.00 | -0.72% | 225,880 |
| 13/07/26 | €69.50 | +0.78% | 151,866 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ERF Stock
Select your edition
All financial news and data tailored to specific country editions
